S&D Co., Ltd (KOSDAQ:260970)

Market Cap	203.94B
Revenue (ttm)	137.35B
Net Income (ttm)	19.29B
Shares Out	2.89M
EPS (ttm)	6,671.71
PE Ratio	10.57
Forward PE	7.04
Dividend	800.00 (1.16%)
Ex-Dividend Date	Dec 29, 2025

Volume	32,666
Average Volume	28,554
Open	72,000
Previous Close	70,000
Day's Range	70,300 - 74,100
52-Week Range	29,000 - 149,800
Beta	0.91
RSI	35.16
Earnings Date	Nov 14, 2025

About S&D Co., Ltd

S&D Co., Ltd develops and sells health functional food in South Korea. The company offers general functional food ingredients, health-oriented functional ingredients, and biological industry materials for the sleeping problems and glycoconjugate gastric functions. It provides health-oriented functional ingredients, such as Lindera glauca extract, Rice bran Extract, MPG-6/MPGT, RCS, and Xanthorrhizol, as well as other materials, including Pagopyridol, SD 1002F, and Panduratin. The company also offers general functional food ingredients comprisin...

• Industry: Miscellaneous Food Preparations And Kindred Products
• Founded: 1998
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 260970

Financial Performance

In 2024, S&D Co., Ltd's revenue was 116.14 billion, an increase of 31.56% compared to the previous year's 88.28 billion. Earnings were 17.03 billion, an increase of 43.45%.